do glp 1 agonists have cardiovascular benefit GLP-1 Receptor in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives GLP-1 Receptor Agonists in Heart
Description
Iida, T., Yamaguchi, T., et al
10.1111/j.1463-1326.2011.01454.x
Possible mechanisms for their beneficial effects in individuals with NAFLD are: (i) reduction of visceral adipose tissue and thus IR
CONTRAINDICATIONS : History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema
Bisphosphonates, denosumab, or other osteoporosis medications should be considered based on standard clinical guidelines
